AstraZeneca - January 2021 - case study 2

Optimised Pathway for Early Identification of HeaRt FAilure in the Community (OPERA) - AstraZeneca

Project Aims and Objectives

• Create a deployable & scalable digital platform for HF diagnosis & treatment initiation.
• Prospectively validate AI analysis of echocardiogram images in pragmatic cohort.
• Create AI models to:
  • Identify those at highest risk of having HF.
  • Support clinical triage and prioritisation of those at highest risk.

Achievements & Milestones

• Waiting times reduced from 12 months to 6 weeks (Jan-Aug 2021)
• Streamlined pathway with greater efficiency and increased capacity.
• Comprehensive HF consultant management plan vs standalone tests.
• HF consultant can remotely manage 20 patients per clinical session vs 10 new patients face to face.

GB-49317 October 2023